Immunomodulatory effect of macrolides: At what cost?

We present the case of a 60-year old female patient, with a 10 year history of non-CF bronchiectasis and use of macrolides as maintenance immunomodulatory treatment, who was diagnosed with macrolide-resistant Mycobacterium avium complex lung disease. Macrolides' immunomodulatory effect is appea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipourou, Maria, Manika, Katerina, Papavasileiou, Apostolos, Pitsiou, Georgia, Lada, Martha, Ntinapogias, Evangelos, Kioumis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821334/
https://www.ncbi.nlm.nih.gov/pubmed/27222784
http://dx.doi.org/10.1016/j.rmcr.2016.01.004
_version_ 1782425572498997248
author Kipourou, Maria
Manika, Katerina
Papavasileiou, Apostolos
Pitsiou, Georgia
Lada, Martha
Ntinapogias, Evangelos
Kioumis, Ioannis
author_facet Kipourou, Maria
Manika, Katerina
Papavasileiou, Apostolos
Pitsiou, Georgia
Lada, Martha
Ntinapogias, Evangelos
Kioumis, Ioannis
author_sort Kipourou, Maria
collection PubMed
description We present the case of a 60-year old female patient, with a 10 year history of non-CF bronchiectasis and use of macrolides as maintenance immunomodulatory treatment, who was diagnosed with macrolide-resistant Mycobacterium avium complex lung disease. Macrolides' immunomodulatory effect is appealing for non- CF bronchiectasis patients, hiding a high risk for resistance emergence.
format Online
Article
Text
id pubmed-4821334
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48213342016-05-24 Immunomodulatory effect of macrolides: At what cost? Kipourou, Maria Manika, Katerina Papavasileiou, Apostolos Pitsiou, Georgia Lada, Martha Ntinapogias, Evangelos Kioumis, Ioannis Respir Med Case Rep Case Report We present the case of a 60-year old female patient, with a 10 year history of non-CF bronchiectasis and use of macrolides as maintenance immunomodulatory treatment, who was diagnosed with macrolide-resistant Mycobacterium avium complex lung disease. Macrolides' immunomodulatory effect is appealing for non- CF bronchiectasis patients, hiding a high risk for resistance emergence. Elsevier 2016-01-15 /pmc/articles/PMC4821334/ /pubmed/27222784 http://dx.doi.org/10.1016/j.rmcr.2016.01.004 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kipourou, Maria
Manika, Katerina
Papavasileiou, Apostolos
Pitsiou, Georgia
Lada, Martha
Ntinapogias, Evangelos
Kioumis, Ioannis
Immunomodulatory effect of macrolides: At what cost?
title Immunomodulatory effect of macrolides: At what cost?
title_full Immunomodulatory effect of macrolides: At what cost?
title_fullStr Immunomodulatory effect of macrolides: At what cost?
title_full_unstemmed Immunomodulatory effect of macrolides: At what cost?
title_short Immunomodulatory effect of macrolides: At what cost?
title_sort immunomodulatory effect of macrolides: at what cost?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821334/
https://www.ncbi.nlm.nih.gov/pubmed/27222784
http://dx.doi.org/10.1016/j.rmcr.2016.01.004
work_keys_str_mv AT kipouroumaria immunomodulatoryeffectofmacrolidesatwhatcost
AT manikakaterina immunomodulatoryeffectofmacrolidesatwhatcost
AT papavasileiouapostolos immunomodulatoryeffectofmacrolidesatwhatcost
AT pitsiougeorgia immunomodulatoryeffectofmacrolidesatwhatcost
AT ladamartha immunomodulatoryeffectofmacrolidesatwhatcost
AT ntinapogiasevangelos immunomodulatoryeffectofmacrolidesatwhatcost
AT kioumisioannis immunomodulatoryeffectofmacrolidesatwhatcost

Ejemplares similares